Literature DB >> 20869331

Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis.

Boris Kandinov1, Amos D Korczyn, Ruth Rabinowitz, Beatrice Nefussy, Vivian E Drory.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by progressive loss of motor neurons, however it is increasingly recognized that nonmotor manifestations may occur, including autonomic nervous system dysfunction. To better understand the autonomic involvement in ALS we measured autonomic functions in transgenic (TG) mice carrying an SOD1 (G93A) mutation and wild-type (WT) control mice. TG mice had a higher heart rate at rest and following stress than WT mice at all ages except for the advanced stages of the disease (19-20weeks of age). The mean pupil diameter at rest was similar in WT and TG mice; however, TG mice had decreased mydriasis following administration of morphine. The rectal temperature did not differ between TG and WT mice at rest, during exposure to cold stress and following administration of morphine (30mg/kg) except for the advanced stages of the disease in which TG mice had significantly lower temperatures than WT mice during cold stress and following morphine administration. The results suggest autonomic nervous system impairment in this ALS model, consistent with clinical data in humans.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 20869331     DOI: 10.1016/j.autneu.2010.09.002

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  8 in total

1.  Pseudo-ischaemic ECG in a patient with amyotrophic lateral sclerosis surviving for a decade.

Authors:  Jian Zhang; Shi-Wei Yang; Zheng Wang; Guang-Ru Wei; Yu-Jie Zhou
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  The sympathetic nervous system regulates skeletal muscle motor innervation and acetylcholine receptor stability.

Authors:  Anna C Z Rodrigues; Maria L Messi; Zhong-Min Wang; Martin C Abba; Andrea Pereyra; Alexander Birbrair; Tan Zhang; Meaghan O'Meara; Ping Kwan; Elsa I S Lopez; Monte S Willis; Akiva Mintz; D Clark Files; Cristina Furdui; Ronald W Oppenheim; Osvaldo Delbono
Journal:  Acta Physiol (Oxf)       Date:  2018-10-22       Impact factor: 6.311

3.  Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis.

Authors:  Maurine C Braun; Alexandra Castillo-Ruiz; Premananda Indic; Dae Young Jung; Jason K Kim; Robert H Brown; Steven J Swoap; William J Schwartz
Journal:  Exp Neurol       Date:  2018-07-18       Impact factor: 5.330

4.  Abnormal electrocardiogram in a patient with amyotrophic lateral sclerosis mimicking myocardial ischaemia.

Authors:  Juana Martínez; César Ramón; César Morís; Julio Pascual; Germán Morís
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

5.  PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Authors:  Cornelia Ringer; Luisa-Sybille Büning; Martin K H Schäfer; Lee E Eiden; Eberhard Weihe; Burkhard Schütz
Journal:  Neurobiol Dis       Date:  2013-03-04       Impact factor: 5.996

Review 6.  The emerging role of the sympathetic nervous system in skeletal muscle motor innervation and sarcopenia.

Authors:  Osvaldo Delbono; Anna Carolina Zaia Rodrigues; Henry Jacob Bonilla; Maria Laura Messi
Journal:  Ageing Res Rev       Date:  2021-02-18       Impact factor: 10.895

7.  Heart and neural crest derivative 2-induced preservation of sympathetic neurons attenuates sarcopenia with aging.

Authors:  Anna Carolina Zaia Rodrigues; Zhong-Min Wang; María Laura Messi; Henry Jacob Bonilla; Liang Liu; Willard M Freeman; Osvaldo Delbono
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-11-30       Impact factor: 12.910

8.  Autonomic etiology of heart block in amyotrophic lateral sclerosis: a case report.

Authors:  Kamal Shemisa; David Kaelber; Sahil A Parikh; Judith A Mackall
Journal:  J Med Case Rep       Date:  2014-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.